Bixing H. Zhao
The United Innovation Of Mengchao Hepatobiliary Technology Key Laboratory Of Fujian Province, 66 Jintang Road
Fuzhou, 350025, China
Fuzhou, 350025, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
p53-R280S mutation confers lenvatinib resistance in hepatocellular carcinoma via Bcl-2-mediated anti-apoptotic signaling.
Journal: Molecular and cellular biochemistry
Published: February 13, 2026
DGKH-PA-mTOR: A pharmacologically druggable metabolic axis underpinning tyrosine-kinase-inhibitor resistance in hepatocellular carcinoma.
Journal: iLIVER
Published: September 08, 2025
Correction: Targeted Inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 25, 2025
Hypoxia-induced exosomal LUCAT1 promotes osimertinib resistance in lung adenocarcinoma by stabilizing c-MET.
Journal: Cell death & disease
Published: April 29, 2025
Utilization of artificial circular RNAs as miRNA sponges and anti-PD-1 scFv expression platforms to suppress hepatocellular carcinoma progression.
Journal: Frontiers in immunology
Published: April 10, 2025
Targeted inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 26, 2025
Reduced glutathione enhances adipose tissue-derived mesenchymal stem cell engraftment efficiency for liver fibrosis by targeting TGFβ1/SMAD3/NOX4 pathway.
Journal: Bioengineering & translational medicine
Published: June 11, 2024
CRISPR/Cas12b assisted loop-mediated isothermal amplification for easy, rapid and sensitive quantification of chronic HBV DNA in one-pot.
Journal: Analytica chimica acta
Published: April 12, 2024
Lnc-PIK3R1, transcriptionally suppressed by YY1, inhibits hepatocellular carcinoma progression via the Lnc-PIK3R1/miR-1286/GSK3β axis.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: January 29, 2024
Circular RNA-based neoantigen vaccine for hepatocellular carcinoma immunotherapy.
Journal: MedComm
Published: November 01, 2023
Chalcomoracin promotes apoptosis and endoplasmic reticulum stress in hepatocellular carcinoma cells.
Chalcomoracin promotes apoptosis and endoplasmic reticulum stress in hepatocellular carcinoma cells.
Journal: The Journal of antibiotics
Published: September 21, 2023
Last Updated: 09/26/2026